Literature DB >> 6347966

Hepatocellular transplantation in rats with toxic induced liver failure: results of iso-, allo- and xenografts.

S Contini, A Pezzarossa, P Sansoni, M P Mazzoni, G C Botta.   

Abstract

Intrasplenic hepatocytes transplantation was carried out in Wistar-Lewis strain inbred rats, after inducing acute hepatic failure by intravenous injection of Dimethylnitrosamine (DMNA) (30 mg/kg). Iso-, allo-(CDF-Fisher strain) and xenogeneic (New Zealand White rabbit) grafts were performed. Liver cells suspension was obtained by mechanical separation. The results demonstrated the efficacy of iso- and allotransplants, but not of xenogeneic hepatocytes, in improving significantly the survival rate compared to the control group. It is concluded that immunogenicity of liver cells is a factor which must be taken into consideration in hepatocyte transplantation. Moreover the absence of liver cells into the spleen at one week after the transplant seems to suggest that an intact liver cell is not necessary to improve survival.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347966

Source DB:  PubMed          Journal:  Ital J Surg Sci        ISSN: 0392-3525


  3 in total

1.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  New method of hepatocyte transplantation and extracorporeal liver support.

Authors:  A A Demetriou; J Whiting; S M Levenson; N R Chowdhury; R Schechner; S Michalski; D Feldman; J R Chowdhury
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

3.  Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation.

Authors:  Dimitrios Papagoras; Apostolos Papalois; Alexandra Tsaroucha; Dimitrios Lytras; John Kyriazanos; Nikoletta Giannakou; Prodromos Laftsidis; Constantine Simopoulos
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.